Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Notes Payables (2021 - 2023)

Pulse Biosciences (PLSE) has 3 years of Notes Payables data on record, last reported at $801000.0 in Q1 2023.

  • For Q1 2023, Notes Payables changed N/A year-over-year to $801000.0; the TTM value through Mar 2023 reached $801000.0, changed N/A, while the annual FY2022 figure was $917000.0, N/A changed from the prior year.
  • Notes Payables reached $801000.0 in Q1 2023 per PLSE's latest filing, down from $917000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.7 million in Q2 2021 and bottomed at $98000.0 in Q3 2022.
  • Average Notes Payables over 3 years is $791666.7, with a median of $859000.0 recorded in 2022.
  • The widest YoY moves for Notes Payables: up 90.98% in 2022, down 90.98% in 2022.
  • A 3-year view of Notes Payables shows it stood at $1.1 million in 2021, then fell by 15.56% to $917000.0 in 2022, then fell by 12.65% to $801000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Notes Payables were $801000.0 in Q1 2023, $917000.0 in Q4 2022, and $98000.0 in Q3 2022.